Examine in vivo muscle energy metabolism in patients with burns, during rest, (prolonged) exercise and recovery.
ID
Source
Brief title
Condition
- Skin and subcutaneous tissue disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
In vivo intramuscular steady-state levels of inorganic phosphate (Pi),
phoshocreatine (PCr), and pH at rest versus (prolonged) exercise, and the
dynamics of Pi, PCr and pH recovery following exercise.
Secondary outcome
• Body composition
- body height (m)
- body weight (kg)
- waist circumference (cm)
• Muscle strength
- maximal isokinetic leg muscle strength (Newton), including Visual Analogue
Scale (VAS) score for pain assessment during the test
- grip strength (Newton)
• Aerobic exercise capacity
- VO2max, FATMAX, peak work rate, peak heart rate, and percentage heart rate
recovery after 1 and 2 minutes
- subjective fatigue and muscle ache score after CPET (scale 0-10)
• Prolonged exercise
- completion of 35 min upright bicycling bout at FATMAX (yes/no; if no,
#minutes)
- completion of 10 min supine bicycling bout at FATMAX in scanner (yes/no; if
no, #minutes)
- subjective fatigue and muscle ache score after each exercise bout (scale
0-10)
• Activity and fatigue
- Habitual Physical Activity Questionnaire
- Brief Fatigue Inventory
Background summary
Central to the process of optimizing burn care and rehabilitation is a
comprehensive understanding of the pathophysiological response. There is
evidence that impaired mitochondrial energy metabolism may play a major role in
the pathophysiology and impaired muscle function documented in patients
following major burn injury. Advanced research is required to further elucidate
the role of skeletal muscle mitochondrial dysfunction in the pathophysiological
response, particularly given the fact that mitochondria are sensitive to
environmental and pharmacological interventions.
Study objective
Examine in vivo muscle energy metabolism in patients with burns, during rest,
(prolonged) exercise and recovery.
Study design
Observational case control study
Intervention
not applicable
Study burden and risks
Patients will be asked to participate in two study sessions, with time between
both sessions of 1-3 weeks.
• session I (site: Martini Hospital) scheduled in combination with a routine
follow-up appointment at the Burn Centre of the Martini Hospital in Groningen.
In order to set the desired exercise workload of maximal individual rate of fat
oxidation (FATMAX; typically ~40% VO2max) in session II, aerobic exercise
capacity (VO2max) needs to be determined. In session 1 therefore, VO2max is
assessed using a standard maximal cardiopulmonary exercise test (CPET; bicycle
ergometry with respiratory gas analysis). Furthermore, body composition (body
height, body weight, waist circumference), maximal isokinetic leg muscle
strength (using a Cybex isokinetic dynamometer) and grip force (using the Citec
hand-held dynamometer) will be assessed.
The assessments are safe and non-invasive and will take approximately 2 hours.
Standard maximal cardiopulmonary exercise testing and isokinetic maximal
strength assessment have been previously used in patients with major burns
without adverse effects (St-Pierre, Choiniere et al. 1998, de Lateur,
Magyar-Russell et al. 2007). Patients will be asked to abstain from heavy
meals, caffeine and alcohol 2 hours prior to the test. After the assessments,
patients will receive two short questionnaires about habitual physical activity
and fatigue. These questionnaires can be filled in at home at any desired time
between the two assessment sessions. This will take approximately 15 minutes.
• session II (site: Neuroimaging Magnetic Resonance Center, University Medical
Center Groningen (UMCG)).
Working muscle metabolism: To determine energy and proton balance in the
muscle during exercise and the kinetics of metabolic recovery following
exercise, serial in vivo 31P MR spectra will be recorded non-invasively from
the m. vastus lateralis of the right leg. To this end, patients will be asked
to perform a 35 min upright bicycling exercise at FATMAX outside the MR scanner
(exercise bout 1) followed by a 10 min supine bicycling exercise at FATMAX
inside the MR scanner (exercise bout 2).
Application of 31P MRS in burn patients enables the non-invasive investigation
of the impact of burn injury on the bioenergetics of working muscles in vivo.
No adverse effects are expected. This and like protocols for in-magnet cycling
has previously been included and approved in clinical investigations of
metabolic myopathy patients protocols: 12-211/K (VLCAD; UMC Utrecht);
NL41313.042.12 (MCAD; UMCG); METC 2014.492 (Acute Nutritional Ketosis in VLCAD;
UMCG). The measurements in session II, including 31P MRS data collection, will
take approximately 2 hours.
Zeestraat 27
Beverwijk 1941 AJ
NL
Zeestraat 27
Beverwijk 1941 AJ
NL
Listed location countries
Age
Inclusion criteria
Patients aged 18-65 years, admitted to the Martini Hospital Burn Center with burns covering 15% or more of total body surface area (TBSA).
Exclusion criteria
- only facial burns
- contraindications for MRI studies
- inability to perform bicycle exercise
- contra-indications for high intensity exercise testing
- known coronary artery disease, positive history for angina pectoris, or changes on ECG suggestive of previous ischaemia without a negative stress test
- intercurrent illness which may influence exercise tolerance (anaemia, musculoskeletal injury, or other undiagnosed illness under investigation)
- pre-existing insulin-dependent diabetes mellitus
- pregnancy or current breastfeeding, or females not taking the oral contraceptive pill
- any other cause which in the opinion of the investigators, may affect the volunteers ability to participate in the study
- insufficient proficiency in Dutch or English to the extent that clear communication is not possible
- loss of, or an inability to give informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL53241.099.15 |
Other | OND1357794 |